These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28480767)

  • 41. Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
    Anttila L; Koskinen P; Kaihola HL; Erkkola R; Irjala K; Ruutiainen K
    Fertil Steril; 1992 Oct; 58(4):697-702. PubMed ID: 1426312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovary disease.
    Martínez-Guisasola J; Guerrero M; Alonso F; Díaz F; Cordero J; Ferrer J
    Gynecol Endocrinol; 2001 Feb; 15(1):14-22. PubMed ID: 11293919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
    Velija-Ašimi Z
    Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.
    Agacayak E; Tunc SY; Sak S; Basaranoglu S; Yüksel H; Turgut A; Gul T
    Med Sci Monit; 2015 Aug; 21():2446-55. PubMed ID: 26292090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.
    Burghen GA; Givens JR; Kitabchi AE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):113-6. PubMed ID: 7350174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
    Elnashar A; Fahmy M; Mansour A; Ibrahim K
    Fertil Steril; 2007 Aug; 88(2):406-9. PubMed ID: 17335818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
    Saadia Z
    Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
    Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.
    Lee H; Oh JY; Sung YA
    Korean J Intern Med; 2013 Jul; 28(4):456-63. PubMed ID: 23864804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome.
    Kazerooni T; Ghaffarpasand F; Kazerooni Y; Kazerooni M; Setoodeh S
    Int J Gynaecol Obstet; 2009 Oct; 107(1):50-3. PubMed ID: 19552904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.
    Mehrabian F; Eessaei F
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S42-4. PubMed ID: 22768457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome.
    Nemati M; Nemati S; Taheri AM; Heidari B
    J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):579-585. PubMed ID: 28698075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.